EMC Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
9,866
-14,027
| -59% | -$9.95K | ﹤0.01% | 298 |
|
|
2025
Q1 | $35K | Hold |
23,893
| – | – | 0.02% | 263 |
|
|
2024
Q4 | $106K | Buy |
23,893
+20,880
| +693% | +$92.6K | 0.06% | 226 |
|
|
2024
Q3 | $225K | Sell |
3,013
-20,880
| -87% | -$1.56M | 0.15% | 138 |
|
|
2024
Q2 | $156K | Hold |
23,893
| – | – | 0.09% | 194 |
|
|
2024
Q1 | $208K | Sell |
23,893
-19,422
| -45% | -$169K | 0.12% | 160 |
|
|
2023
Q4 | $496K | Hold |
43,315
| – | – | 0.33% | 29 |
|
|
2023
Q3 | $417K | Buy |
43,315
+41,338
| +2,091% | +$398K | 0.31% | 33 |
|
|
2023
Q2 | $121 | Sell |
1,977
-41,338
| -95% | -$2.53K | 0.09% | 197 |
|
|
2023
Q1 | $456K | Hold |
43,315
| – | – | 0.38% | 27 |
|
|
2022
Q4 | $537K | Buy |
43,315
+5,558
| +15% | +$68.9K | 0.48% | 12 |
|
|
2022
Q3 | $391K | Hold |
37,757
| – | – | 0.36% | 24 |
|
|
2022
Q2 | $435K | Buy |
37,757
+12,821
| +51% | +$148K | 0.37% | 24 |
|
|
2022
Q1 | $299K | Buy |
+24,936
| New | +$299K | 0.21% | 60 |
|